STAT3 and cancer: With a large number of human cancers, both EBV-related [35, 36] and unrelated [31], demonstrating constitutively active STAT3, the predictive STAT3-gene signature also opens the possibility of personalizing synthetic lethal therapy for patients with such STAT3hi cancers.